Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on Februar...
08 February 2019 - 1:35AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, February 21, 2019 at 5:00 pm (Eastern Time) to discuss
the financial results for the fourth quarter and full year 2018,
recent business developments, financial outlook for full year 2019,
and revenue guidance for the first quarter of 2019.
This conference call can be accessed live by telephone or by
webcast:
Live Teleconference
Information: |
Dial in
number: (855) 766-6521 |
International dial in: (262) 912-6157 |
Conference ID: 2299983 |
|
Live
Webcast Information: |
Visit
https://edge.media-server.com/m6/p/ow37uwh9 for the live webcast
feed. |
A replay of the call can be accessed on Emergent’s website
emergentbiosolutions.com under “Investors.”
About Emergent
BioSolutionsEmergent BioSolutions Inc. is a global life
sciences company seeking to protect and enhance life by focusing on
providing specialty products for civilian and military populations
that address accidental, deliberate, and naturally occurring public
health threats. We aspire to be a Fortune 500 company recognized
for protecting and enhancing life, driving innovation, and living
our values. Additional information about the company may be found
at www.emergentbiosolutions.com. Find us on LinkedIn and follow us
on Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280BurrowsR@ebsi.com
Media Contact:Lynn KiefferVice
President, Corporate
Communications240-631-3391KiefferL@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2023 to Jul 2024